The findings indicated that patients in the high WISP1 expression group exhibited markedly reduced survival times, thereby establishing a robust association between elevated WISP1 expression and adverse clinical outcomes in ESCC patients (Figures 2A–C). Here, CCN4 is linked to esophageal squamous cell carcinoma.